Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01188187
Show Display Options
Rank Status Study
1 Completed Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Custirsen Sodium, Docetaxel, Prednisone;   Drug: Docetaxel, Prednisone

Indicates status has not been verified in more than two years